作者: Judith E.K.R. Hentzen , Steven J. de Jongh , Patrick H.J. Hemmer , Willemijn Y. van der Plas , Gooitzen M. van Dam
DOI: 10.1002/JSO.25106
关键词:
摘要: Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC) as a curative approach. One major prognostic factor that affects survival is completeness of cytoreduction. Molecular Fluorescence Guided Surgery (MFGS) novel intraoperative imaging technique improve tumor identification in the future, potentially preventing over- and under-treatment these patients. This narrative review outlines chronological overview MFGS development patients PC origin.